Conversely, SIRT3 can enhance the cell proliferation, invasion, and EMT of triple-negative breast cancer cells by promoting mitochondrial biogenesis and function via MnSOD activation 78. This evidence concerns the gene SOD2 and triple-negative breast carcinoma.